Biodesix Inc financial data

Symbol
BDSX on Nasdaq
Industry
Services-Medical Laboratories
Location
919 West Dillon Road, Louisville, Colorado
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 135 % +8.02%
Debt-to-equity 1.05K % -46.6%
Return On Equity -525 % +69.7%
Return On Assets -45.8 % +45.5%
Operating Margin -54.7 % +56%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 145M shares +84.7%
Common Stock, Shares, Outstanding 145M shares +84.6%
Entity Public Float 36.6M USD +7.33%
Common Stock, Value, Issued 145K USD +83.5%
Weighted Average Number of Shares Outstanding, Basic 127M shares +62%
Weighted Average Number of Shares Outstanding, Diluted 127M shares +62%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 60.9M USD +46.3%
Research and Development Expense 8.43M USD -33.6%
Operating Income (Loss) -33.3M USD +35.7%
Nonoperating Income (Expense) -2.57M USD -5.85%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -44.5M USD +32.7%
Earnings Per Share, Basic -0.45 USD/shares +57.5%
Earnings Per Share, Diluted -0.45 USD/shares +57.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 42.2M USD +143%
Accounts Receivable, after Allowance for Credit Loss, Current 10.1M USD +146%
Other Assets, Current 5.23M USD +40.8%
Assets, Current 57.6M USD +128%
Property, Plant and Equipment, Net 28M USD +47.5%
Operating Lease, Right-of-Use Asset 1.77M USD -29.1%
Intangible Assets, Net (Excluding Goodwill) 6.88M USD -22.4%
Goodwill 15M USD 0%
Other Assets, Noncurrent 6.56M USD -6.11%
Assets 116M USD +49.2%
Accounts Payable, Current 2.22M USD -36.6%
Employee-related Liabilities, Current 4.65M USD +18.8%
Accrued Liabilities, Current 8.32M USD +19.2%
Contract with Customer, Liability, Current 447K USD -58.2%
Liabilities, Current 17.6M USD -37.2%
Contract with Customer, Liability, Noncurrent 400K USD
Operating Lease, Liability, Noncurrent 25.5M USD +35.5%
Other Liabilities, Noncurrent 744K USD -17%
Liabilities 79.6M USD -5.95%
Retained Earnings (Accumulated Deficit) -444M USD -11.1%
Stockholders' Equity Attributable to Parent 36.3M USD
Liabilities and Equity 116M USD +49.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.3M USD -99.2%
Net Cash Provided by (Used in) Financing Activities 791K USD
Net Cash Provided by (Used in) Investing Activities -273K USD +96.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 145M shares +84.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.8M USD +17%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 42.3M USD +142%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.48M USD +42.9%
Deferred Tax Assets, Valuation Allowance 93M USD +12.7%
Deferred Tax Assets, Gross 95M USD +12.7%
Operating Lease, Liability 25.8M USD +26.9%
Depreciation 900K USD +200%
Payments to Acquire Property, Plant, and Equipment 234K USD -97%
Lessee, Operating Lease, Liability, to be Paid 45.8M USD -5.76%
Property, Plant and Equipment, Gross 35.3M USD +32.7%
Operating Lease, Liability, Current 300K USD -80.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.17M USD +3.45%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.91M USD +62.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 20M USD -12.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.06M USD -1.96%
Deferred Tax Assets, Operating Loss Carryforwards 72.7M USD +2.68%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 1.04M USD +8.93%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.15M USD +2.17%
Additional Paid in Capital 480M USD +22.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.48M USD -24.9%
Deferred Tax Assets, Net of Valuation Allowance 2M USD +12.8%
Share-based Payment Arrangement, Expense 5.89M USD -10.5%
Interest Expense 9.18M USD -11.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%